Quantification of Immune Dysregulation by Next-generation Polymerase Chain Reaction to Improve Sepsis Diagnosis in Surgical Patients

Annals of Surgery

Volumn 269, Issue 3, 2019, Pages 545-553

  Almansa, Raquel ^a   Ortega, Alicia ^a   Ávila Alonso, Ana ^a   Heredia Rodríguez, Maria ^a   Martín, Silvia ^b   Benavides, Diana ^a   Martín Fernandez, Marta ^a   Rico, Lucia ^a   Aldecoa, César ^b   Rico, Jesús ^b   López De Cenarruzabeitia, Iñigo ^a   Beltrán De Heredia, Juan ^a   Gomez Sanchez, Esther ^a   Aragón, Marta ^a   Andrés, Cristina ^a   Calvo, Dolores ^a   Andaluz Ojeda, David ^a   Liu, Pilar ^a   Blanco Antona, Francisco ^a   Blanco, Lydia ^c   Gómez Herreras, Jose Ignacio ^a   Tamayo, Eduardo ^a   Bermejo Martin, Jesus F ^a   more..

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c Center for Hemodonation and Hemotherapy of Castilla y León   (Spain)

Author keywords

diagnosis; droplet digital polymerase chain reaction; expression; gene; sepsis; surgical

Indexed keywords

C REACTIVE PROTEIN; CD28 ANTIGEN; CD3 ANTIGEN; CD3E PROTEIN; CD40 LIGAND; CD40LG; HLA DR ANTIGEN; INDUCIBLE T CELL COSTIMULATOR; LTF PROTEIN; MESSENGER RNA; NEUTROPHIL COLLAGENASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OLFM4 PROTEIN; PROCALCITONIN; PROTEIN; PRTN3 PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DROPLET DIGITAL POLYMERASE CHAIN REACTION; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNE DYSREGULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEXT GENERATION SEQUENCING; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURGICAL INTENSIVE CARE UNIT; SURGICAL PATIENT; TRANSCRIPTOMICS; AGED; BLOOD; CLINICAL TRIAL; GENETIC MARKER; IMMUNOLOGY; IMMUNOPATHOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PROCEDURES; REGRESSION ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; GENETIC MARKERS; HUMANS; IMMUNE SYSTEM DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEPSIS;

EID: 85022217736     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000002406     Document Type: Article

References (30)

1. Bermejo-Martin JF, Andaluz-Ojeda D, Almansa R, et al. Defining immunological dysfunction in sepsis: a requisite tool for precision medicine. J Infect. 2016;72:525-536.
2. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801-810.
3. Bermejo-Martin JF, Tamayo E, Andaluz-Ojeda D, et al. Characterizing systemic immune dysfunction syndrome to fill in the gaps of SEPSIS-2 and SEPSIS-3 definitions. Chest. 2017;151:518-519.
4. Almansa R, Heredia-Rodríguez M, Gomez-Sanchez E, et al. Transcriptomic correlates of organ failure extent in sepsis. J Infect. 2015;70: 445-456.
5. Johnson SB, Lissauer M, Bochicchio GV, et al. Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg. 2007;245: 611-621.
6. Sweeney TE, Shidham A, Wong HR, et al. A comprehensive time-coursebased multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med. 2015;7:287ra71.
7. Kangelaris KN, Prakash A, Liu KD, et al. Increased expression of neutrophilrelated genes in patients with early sepsis-induced ARDS. Am J Physiol Lung Cell Mol Physiol. 2015;308:L1102-L1113.
8. Shanley TP, Cvijanovich N, Lin R, et al. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med Camb Mass. 2007;13:495-508.
9. Parnell GP, Tang BM, Nalos M, et al. Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock Augusta Ga. 2013;40:166-174.
10. Cajander S, Bäckman A, Tina E, et al. Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis. Crit Care Lond Engl. 2013;17:R223.
11. Cajander S, Tina E, Bäckman A, et al. Quantitative real-time polymerase chain reaction measurement of HLA-DRA gene expression in whole blood is highly reproducible and shows changes that reflect dynamic shifts in monocyte surface HLA-DR expression during the course of sepsis. PLoS One. 2016;11:e0154690.
12. Hindson CM, Chevillet JR, Briggs HA, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10:1003-1005.
13. Tamayo E, Almansa R, Carrasco E, et al. Quantification of IgM molecular response by droplet digital PCR as a potential tool for the early diagnosis of sepsis. Crit Care Lond Engl. 2014;18:433.
14. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
16. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426-435.
17. Giannakopoulos K, Hoffmann U, Ansari U, et al. The use of biomarkers in sepsis: a systematic review. Curr Pharm Biotechnol. 2017 [Epub ahead of print].
18. Zhang H-B, Chen J, Lan Q-F, et al. Diagnostic values of red cell distribution width, platelet distribution width and neutrophil-lymphocyte count ratio for sepsis. Exp Ther Med. 2016;12:2215-2219.
19. Almansa R, Tamayo E, Heredia M, et al. Transcriptomic evidence of impaired immunoglobulin G production in fatal septic shock. J Crit Care. 2014;29: 307-309.
20. Shen Z-G, Guo J-L, Li D-S. Screening of differentially expressed genes related to severe sepsis induced by multiple trauma with DNA microarray. Eur Rev Med Pharmacol Sci. 2014;18:734-739.
21. Yazdan-Ashoori P, Liaw P, Toltl L, et al. Elevated plasma matrix metalloproteinases and their tissue inhibitors in patients with severe sepsis. J Crit Care. 2011;26:556-565.
22. Wong HR, Weiss SL, Giuliano JS, et al. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One. 2014;9:e86242.
23. Solan PD, Dunsmore KE, Denenberg AG, et al. A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med. 2012;40:379-387.
24. Basu RK, Standage SW, Cvijanovich NZ, et al. Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray. Crit Care Lond Engl. 2011;15:R273.
25. Alder MN, Opoka AM, Lahni P, et al. Olfactomedin-4 is a candidate marker for a pathogenic neutrophil subset in septic shock. Crit Care Med. 2017;45:e426-e432.
26. Wang M, Zhang Q, Zhao X, et al. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the emergency department: an observational study. Crit Care Lond Engl. 2014;18:634.
27. Zhang A, Cai Y, Wang P-F, et al. Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis. Crit Care. 2016;20:41.
28. Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259-271.
29. Cazalis M-A, Friggeri A, Cavé L, et al. Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care Lond Engl. 2013;17:R287.
30. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006;32:1175-1183.